Gonzales Melissa
Genentech, San Francisco, CA, USA
Achieving personalized healthcare for all people, including the most vulnerable Hispanic communities, may appear to be an insurmountable task or an impossible reality. Biotech pioneer and thought leader Genentech, a member of the Roche Group, has taken deliberate and strategic steps toward reaching this goal. Strategic priorities for this effort include developing policies focused on inclusive practices, increasing the amount of genomic data and scientific insights from underrepresented populations, and leveraging partner relationships to develop actionable strategies to increase clinical research participation. Through collaboration with the broader healthcare ecosystem, progress can be made to help remove systemic barriers for communities of color and build a future of precision medicine.
为所有人，包括最脆弱的西班牙裔社区实现个性化医疗保健，这似乎是一项无法完成的任务或不可能实现的现实。罗氏集团成员、生物技术先驱和思想领袖基因泰克公司，已朝着实现这一目标采取了深思熟虑的战略举措。这项工作的战略重点包括制定注重包容性做法的政策，增加来自代表性不足人群的基因组数据和科学见解的数量，并利用合作伙伴关系制定可行的战略，以提高临床研究参与度。通过与更广泛的医疗保健生态系统合作，可以取得进展，帮助消除有色人种社区的系统性障碍，并打造精准医疗的未来。
